BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/9/2024 7:18:19 AM | Browse: 227 | Download: 6
Publication Name World Journal of Psychiatry
Manuscript ID 95214
Country South Korea
Category Psychiatry
Manuscript Type Minireviews
Article Title Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment
Manuscript Source Invited Manuscript
All Author List Uchenna Esther Okpete and Haewon Byeon
Funding Agency and Grant Number
Funding Agency Grant Number
Basic Science Research Program through the National Research Foundation of Korea Funded by the Ministry of Education NRF-RS-2023-00237287, and NRF-2021S1A5A8062526
Local Government-University Cooperation-Based Regional Innovation Projects 2021RIS-003
Corresponding Author Haewon Byeon, DSc, PhD, Associate Professor, Director, Department of Digital Anti-aging Healthcare (BK21), Inje University, No. 197 Injero, Gyeonsangnamdo, Gimhae 50834, South Korea. bhwpuma@naver.com
Key Words Precision medicine; Psychiatric treatment; Genomic data; Machine learning; Deep learning; Clinical decision making; Data privacy
Core Tip This paper explores the convergence of precision medicine and artificial intelligence (AI) in psychiatric care, focusing on tailoring treatments to individuals' genetic backgrounds. It underscores the complexity of psychiatric disorders, attributed to varied genetic, environmental, and lifestyle factors, and the role of AI in navigating these challenges by analyzing large genomic datasets. Despite obstacles such as data privacy, computational requirements, and model generalization, the study highlights the necessity for ethical guidelines and regulatory frameworks for AI use in psychiatric genetics. Furthermore, it stresses the importance of interdisciplinary collaboration to effectively address the AI-related implementation challenges in precision medicine.
Citation <p>Okpete UE, Byeon H. Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment. <i>World J Psychiatry</i> 2024; 14(8): 1148-1164</p>
Received
2024-04-04 12:09
Peer-Review Started
2024-04-04 12:09
To Make the First Decision
Return for Revision
2024-05-09 07:03
Revised
2024-06-13 12:44
Second Decision
2024-07-09 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-07-09 07:18
Articles in Press
2024-07-09 07:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-08-06 02:27
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com